Fuse Oncology
PrivateLast Round
VC Round
Sep 8, 2023
Total Funding Raised
$2.95M
Company Overview
Fuse Oncology is an oncology software solutions company that develops AI-powered SaaS solutions to streamline radiation oncology workflows and improve clinical efficiency.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Revenue Cycle, EHR & EMR, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fuse Oncology Comparables
Compare Fuse Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoLens | 77% | |
| Radformation | 74% | |
| Shavara | 73% |
Fuse Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 8, 2023 | ||||
| Series A | Jun 1, 2023 | ||||
| Seed | May 27, 2022 |
Key People
Founding team and executive leadership
Fuse Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northeast Georgia Health Ventures | Series A |
| Cone Health Ventures | Series A |
| First Trust Capital Partners | Seed |
| First Launch Capital Fund | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2025
Showcased live clinical AI solutions at ASTRO 2025.
- Mar 13, 2025
Developing a dedicated application for ACROPath to enhance clinical workflows.
Recent news
Latest coverage and updates
- launchesSep 29, 2026
Fuse Oncology launched proof of concept for end-to-end Radiation Oncology workflow on Sep 28th '26
- attends_eventSep 27, 2026
Fuse Oncology to showcase S!GNAL workflow experience at ASTRO 2026 in Massachusetts on Sep '26
- integrates_withSep 27, 2026
Fuse Oncology to showcase a prototype workflow with GE Healthcare in Massachusetts on Sep 28th '26
Fuse Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fuse Oncology's valuation, stock price, and market status.
Is Fuse Oncology a public or private company?
Fuse Oncology is a private company.
What is the current stock price of Fuse Oncology?
Fuse Oncology is a private company, so its shares have no public market price. Caplight tracks Fuse Oncology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fuse Oncology worth (valuation)?
Valuation information for Fuse Oncology is not publicly available.
Can I buy Fuse Oncology stock?
Fuse Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fuse Oncology's last funding round?
Fuse Oncology's most recent funding round was VC Round on September 8, 2023.
Who are the main investors in Fuse Oncology?
Key investors in Fuse Oncology include Northeast Georgia Health Ventures, Cone Health Ventures, First Launch Capital Fund.
Will Fuse Oncology IPO soon?
No public IPO plans have been announced for Fuse Oncology.
How can I track Fuse Oncology secondary market activity?
Caplight tracks bids, offers, and trades in Fuse Oncology's shares on secondary markets.